Check out our latest news
A decade in the making - $34 million dollars committed to research
We are excited and proud to announce that in the 2022/23 financial year, we are committing a further $5 million to neurological research!
Changes to REBIF listing on PBS
For Australians living with MS, REBIF will no longer be available on the Pharmaceutical Benefits Scheme (PBS) from 1 December 2022.
Carers: The Unsung Heroes
Who might be these invisible heroes? These people are commonly known as ‘carers’, but ‘common’ and ‘ordinary’ they are not.